“At Wexler Wallace, our success comes from a special dedication to exposing the truth, even in the face of increasingly sophisticated frauds. There is nothing more rewarding.”
Bethany joined Wexler Wallace in 2012 and focuses her practice on cases involving healthcare, consumer protection and whistleblower-false claims. Her caseload is diverse, spanning the firm’s pharmaceutical antitrust cases to false claims cases and investor litigation.
Early in her career, Bethany and her team obtained asylum for a pro bono client who had previously been persecuted in her home country. Playing a formative role in her experiences as an attorney, this case gave Bethany a taste of satisfaction and the gratification of correcting policy injustices.
In 2016 Bethany and her team took on socially important litigation, representing the City of Chicago (along with co-counsel) against multiple defendant pharmaceutical companies for their unlawful and deceptive marketing of opioids for the treatment of chronic non-cancer pain. Despite knowing the opioids pose a risk of addiction, the pharmaceutical companies executed aggressive marketing campaigns that overstated the benefits of long-term opioid use and misrepresented the risks of these dangerous drugs. Bethany continues to take on a variety of cases in order to seek relief for clients.